news
From cancer evolution to personalised therapies
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
List view / Grid view
Personalised Medicine
news
Artificial Medical Intelligence to introduce medical record tech
AMI has released the full version of HCC Coding as part of the EMscribe suite of tools in support of medical records processing and abstraction.
news
Arming T-cells to channel aggression against cancer
Scientists have armed immune cells with a new surface molecule that causes them to respond aggressively when they encounter a protein that tumours actually use to camouflage themselves from the immune system. Researchers from the Helmholtz Zentrum München and various partners introduced the method in ‘Cancer Research’.
news
SOPHiA artificial intelligence empowers liquid biopsies to fight cancer
Sophia Genetics injects artificial intelligence in liquid biopsies to accelerate early detection of cancer and monitor treatments’ effectiveness.
news
Queen’s researchers breakthrough discovery in fight against bowel cancer
New research led by Queen’s University Belfast has discovered how a genomic approach to understanding bowel cancer could improve the prognosis and quality of life for patients.
news
Healing wounds with cell therapy
An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds...
news
Removing old cells could extend joint health & stop osteoarthritis
In a preclinical study in mice and human cells, researchers report that selectively removing old or 'senescent' cells from joints could stop and even reverse the progression of osteoarthritis.
news
Diagnosing cancer: new process for identifying biomarkers established
Scientists have established a process for identifying biomarkers for the diagnosis of different types of cancer.
news
£10 million pancreatic cancer research fund for precision medicine
The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK.
news
New tool developed to help avoid adverse drug reactions
Medicines are an important part of treating and preventing disease in adults and children. The ideal medicine would have no side effects or adverse drug reactions (ADRs) as they are also called, but the reality is all medicines can cause unwanted effects, in some people.
news
AstraZeneca provide insight into biomarkers and personalised treatment at Asthma & COPD 2017
SMi’s 13th annual Asthma & COPD conference returns to London on the 29 and 30 March 2017...
news
Global partnership launched to enable personalised therapies in multiple sclerosis
In this project, universities and companies across 11 European countries and the US will unite efforts to tailor the development and application of therapies to the individual MS patient.
article
Exploring the need for mutation-specific treatments in cystic fibrosis
Despite that over 1,900 mutations of the cystic fibrosis transmembrane conductance regulator cause cystic fibrosis, only two treatment options exist.
article
Personalised Medicines In-Depth Focus 2016
In this Personalised Medicines In-Depth Focus, Dr Adrian Harel talks about the importance of developing a diagnostic test and better treatments for traumatic brain injury. Plus, Caroline Richards, Editor of Drug Target Review explores the need for mutation specific treatments in cystic fibrosis...